Volunteer loses digits after drug trial

June 26, 2006

A drug trial gone wrong has left a 20-year-old London man with the prospect of losing all his fingers and toes.

Trainee plumber Ryan Wilson developed gangrene in both his hands and feet after taking part last March in the test of an arthritis drug developed by TeGenero for U.S. researchers Parexel, Britain's Daily Mirror reported Monday.

Six men had multiple organ failure after testing the drug but an official investigation into the trial found no evidence of problems. The drug caused volunteer's heads to swell like the Elephant Man.

Wilson expected to lose just a few finger tips but at his last checkup doctors told him to prepare for amputation in a month.

His family does not know how long it will be before he can walk again.

Copyright 2006 by United Press International

Explore further: Drug targeting tumor metabolism enters clinical trial

Related Stories

Drug targeting tumor metabolism enters clinical trial

October 26, 2016

The University of Texas MD Anderson Cancer Center's Institute for Applied Cancer Science (IACS) has initiated the first clinical study of a novel drug designed to starve cancer cells, IACS-10759. The study will enroll patients ...

Recommended for you

Cholesterol test for one-year-olds? Study says it could help

October 26, 2016

What if a blood test could reveal that your child is at high risk for early heart disease years in the future, giving you a chance to prevent it now? A big study in England did that—screening thousands of babies for inherited ...

High rate of antidepressant use after cancer

October 26, 2016

(HealthDay)—Treatment for depression and anxiety is nearly twice as common among U.S. cancer survivors as it is for those who never had the disease, a new study finds.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.